Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other neoplasm 1

Conditions

Neoplasms 13Lymphoma 8Lymphoma, Non-Hodgkin 7Recurrence 4Solid Tumor 3Melanoma 3Lymphoma, Large-Cell, Anaplastic 3Advanced Solid Tumors 3Solid Tumors 2Hodgkin Disease 2Hematologic Neoplasms 2Hematologic Diseases 2Carcinoma, Non-Small-Cell Lung 2Solid Tumours 1Solid Tumor, Adult 1Sarcoma, Synovial 1Sarcoma 1Rhabdoid Tumor 1Prostatic Neoplasms 1Neoplasm Metastasis 1Multiple Myeloma 1Mesothelioma 1Malignancies Multiple 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Colorectal Neoplasms 1Carcinoma 1Advanced Solid Tumours 1Advanced Solid Tumor 1Advanced Solid Neoplasm 1

Interventions

tipifarnib 1soybean oil, phospholipid emulsion 1penpulimab 1Sunscreening Agents 1Spironolactone 1Sorafenib 1Rifampin 1Morphine 1Methods 1Itraconazole 1Irinotecan 1Injections 1Infusions, Intravenous 1Hydrocortisone 1Genetic Testing 1Genetic Counseling 1Fat Emulsions, Intravenous 1Educational Status 1Early Intervention, Educational 1Doxycycline 1Docetaxel 1Counseling 1Cordotomy 1Acetates 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Advanced Malignant Neoplasm × Rifampin × Clear all
NCT06165822 2023-12-12

A Study to Evaluate Drug-Drug Interaction of TQB3909 Tablets

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
40 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡